Research Projects

The key objectives of AE's 2016 activities are as follows:

• Increasing knowledge about current national dementia policies in order to promote best practices and reduce existing inequalities in dementia care in Europe;
• Promoting collaboration and exchange on ethical issues linked to dementia; Improving the involvement of people with dementia in...

The key objectives of Alzheimer Europe's 2017 operating grant are: the inventory and comparison of care standards for care services for people with dementia and their carers and the publiciation of results in the 2017 Dementia in Europe Yearbook, the analysis of ethical issues linked to societal obligations to people with dementia and the...

As part of its 2018 operating grant, Alzheimer Europe will aim to:

• Provide a voice to people with dementia by carrying out an inventory and analysis of existing working groups of people with dementia, their membership, working methods and findings and producing a report with the findings and identified good practices;
• Make dementia a European...

This application for a four-year framework partnership agreement is fully focused on dementia, one of the areas specifically identified as a priority area in the 2017 Call for proposals for operating grants. It builds on the work carried out by Alzheimer Europe in successive operating grants as part of its current framework partnership agreement...

In 2019, AE will:Ensure that the voices of people with dementia are duly included in all operating grant activities by involving its European Working Group of People with Dementia, organise at least three meetings of the group and collaborate closely with the 2nd Joint Action on Dementia and develop recommendations on dementia-friendly and dementia...

In 2020, AE will: Ensure that the voices of people with dementia are duly included in all operating grant activities and organise four meetings of the European Working Group of People with Dementia; Develop a guide for dementia-inclusive meetings, transport and venues building on the expectations and experiences of EWGPWD members; Collect...

Alzheimer Europe defines its mission as "changing perceptions, practice and policy in order to improve the access of people with dementia and their carers to treatment option and care services". To achieve its mission, Alzheimer Europe has defined the following six objectives in its Strategic Plan which covers the period of 2006-2010: Representing...

Alzheimer Europe (AE) defines its mission as "changing perceptions, practice and policy in order to improve the access of people with dementia and their carers to treatment options and care services".

Alzheimer’s disease (AD) is central to the rapidly growing and crushing ageing challenge that threatens to economically undermine today’s health care system. AD prevalence will grow to over 100m cases in 2050. AD is incurable, but can be prevented. Detecting pre-symptomatic signs of AD in at-risk groups and intervening early may be the only viable...

Beta-amyloid (β-amyloid) deposition is considered to be a necessary - but not sufficient - step on the path towards Alzheimer’s disease (AD). Depiction of brain β-amyloid in vivo can support an early diagnosis, and even provide an opportunity for consider secondary prevention of AD. Currently, however, the value of β-amyloid PET remains elusive...

Dementia is caused by a range of illnesses and disorders that damage the brain either directly or indirectly. With the rise of the ageing population in the EU, dementia is becoming a serious problem. Digital health interventions have the potential to improve the accessibility and effectiveness of palliative care. Palliative care is an area where...

Postoperative delirium (POD) is characterized by the progressive deterioration of sensory/cognitive function after surgery with incidences of up to 30-80%. It is frequently followed by postoperative cognitive dysfunction (POCD) which tends to persist over time. In elderly patients, POCD resembles chronic dementia and appears to accelerate the...